🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Frailty Among Renal Transplant Recipients and Relation to Chronic Allograft Dysfunction

RecruitingNAAges 18 Years - anyAllAlexandria University
NCT07181096 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of the study is to assess prevalence of frailty among renal transplant recipients in Alexandria University Hospitals and to study the relation between frailty and chronic allograft dysfunction.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Renal transplanted patients with GFR more than 30 Exclusion Criteria: * Mentally or physically unfit patients. * Amputation of lower limb. * Active neoplasia, chronic liver disease, previous immunological disease. * Psychiatric disorders. * Pregnancy.
💊

What it tests

  • assessment of frailty
📍

Where

1 site
Faculty of Medicine, Aexandria University
Alexandria, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy